PathoSearch is now in early access.

Join the waitlist

AI-powered tissue analysis, validated by pathologists

H&E
cell classification

Who We Serve

Life Sciences

Leading technologies for research and biomarker development, from hypothesis generation to clinical trial biomarkers.

Clinical

Support for the pathology lab, from resolving difficult cases to faster triage, better quantification, and fewer failed tests – all without leaving your workflow.

Academics

Research tools based on Aignostics products, available free of charge to support high-impact academic research.

Who We Are

Interdisciplinary team with deep functional expertise

Aignostics is a spin-off from Charité Berlin, one of Europe’s largest and most esteemed university hospitals. Today, our team has grown to include a diverse array of cross-functional experts working from our offices in Berlin and New York.

/CERTIFICATION

ISO 13485 and 27001 certified

GCP-ready clinical trial platform

/Recent Awards

In the news

16.10.2026

Aignostics Launches HETA Clinical, a New Family of AI Products that Speed Up Pathology Workflows and Reduce Failed Molecular Tests

12.9.2026

Aignostics Launches PathoSearch, a Visual Search Engine for Pathology Cases

23.6.2026

Atlas H&E-TME Exceeds the Performance of Expert Pathologists

Stay in the loop

Fill out the form to subscribe to our newsletter for updates on how we're advancing pathology globally with our products.

AI-powered tissue analysis, validated by pathologists.